PharMerica accused of taking kickbacks to expand misuse of anti-seizure drug in nursing homes
“PharMerica Corp., the nation’s second-largest operator of institutional pharmacies, has agreed to settle two federal healthcare fraud lawsuits, one of which accuses the Louisville-based company of taking kickbacks to help expand the misuse of an anti-seizure drug in nursing homes during an 11-year period,” James McNair reports for the Kentucky Center for Investigative Reporting.
“The separate settlement agreements, both previously unreported, were disclosed in federal court filings in Abingdon, Va., and Milwaukee in December,” McNair writes. “Neither agreement has been finalized, and the terms of the settlements were not disclosed.”
“Spokespersons for the U.S. Attorney’s offices in Virginia and Wisconsin would not discuss the deals or provide a timetable for finalizing the settlements,” McNair writes. “PharMerica chief financial officer David Froesel did not return phone calls.”
PharMerica has 6,000 employees, 200 of them in Louisville.